Day: February 14, 2025

Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision

Written by Customer Service on February 14, 2025. Posted in Public Companies.

WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, reaffirms his commitment to preserving equity for shareholders. Amid ongoing discussions about financing approaches in the biotech sector, Dr. Saadi emphasizes his distinct strategy, which prioritizes efficiency, asset ownership, and a path to revenue. “I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a practical standpoint, it’s simply not relevant to us when you consider the following:Strong Asset Base: Tevogen Bio believes its assets are valued in the billions. This value...

Zefiro Methane Corp. Announces Quarterly Earnings with Revenue of USD $7.5 Million

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

This figure represents an approximate 9% year-over-year expansion of revenue FORT LAUDERDALE, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) — ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB US: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced the Company’s consolidated financial results for the fiscal quarter ended December 31, 2024 (“fiscal quarter 2”).Zefiro generated revenue of $7.5 million USD for fiscal quarter 2, an approximate 9% increase compared to the quarter ending December 31, 2023. The second fiscal quarter is seasonally affected by interruptions in environmental remediation operations due to adverse weather conditions, which are expected to be mitigated by further expansion into Texas, Oklahoma, and Louisiana.The Company yielded gross profit of $0.6 million USD in fiscal quarter 2.Revenue...

Peyto Exploration & Development Corp. Confirms Monthly Dividend for March 14, 2025

Written by Customer Service on February 14, 2025. Posted in Dividend Reports And Estimates.

CALGARY, Alberta, Feb. 14, 2025 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to February 2025 of $0.11 per common share is to be paid on March 14, 2025, for shareholders of record on February 28, 2025. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the President and CEO and includes estimates of monthly capital expenditures and production. For further information please contact: Jean-Paul LachancePresident and...

Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older

Written by Customer Service on February 14, 2025. Posted in Public Companies.

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers. On track for commercial launch in the U.S. in the first half of 2025. A Tropical Disease Priority Review Voucher was awarded to the Company upon approval.COPENHAGEN, Denmark, February 14, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Food and Drug Administration (FDA) has approved VIMKUNYA™ (Chikungunya Vaccine, Recombinant) for injection, the first virus-like particle (VLP) single-dose chikungunya vaccine in the U.S. for persons 12 years of age and older. The FDA approved VIMKUNYA under Priority Review, based on results from two phase 3 clinical trials which enrolled more than 3,500 healthy individuals 12 years of age and older. The studies met their primary...

Bogota Financial Corp. Reports Results for the Three and Twelve Months Ended December 31, 2024

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

TEANECK, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) — Bogota Financial Corp. (NASDAQ: BSBK) (the “Company”), the holding company for Bogota Savings Bank (the “Bank”), reported a net loss for the three months ended December 31, 2024 of $930,000 or $0.07 per basic and diluted share, compared to a net loss of $1.2 million or $0.09 per basic and diluted share for the comparable prior year period. The Company reported a net loss for the year ended December 31, 2024 of $2.2 million or $0.17 per basic and diluted share compared to net income of $643,000, or $0.05 per basic and diluted share, for the prior year. On April 24, 2024, the Company announced it had received regulatory approval to repurchase up to 237,090 shares of its common stock, which was approximately 5% of its then outstanding common stock (excluding shares held by Bogota Financial,...

Treasure Global Inc. Reports Second Quarter Year 2025 Financial Results

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

NEW YORK and KUALA LUMPUR, Malaysia, Feb. 14, 2025 (GLOBE NEWSWIRE) — Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a leading e-commerce platform operator, today announced its financial results for the second quarter ended December 31, 2024. Key Financial HighlightsRevenue for the second quarter was $0.30 million, a 46% increase from $0.21 million in the first quarter of fiscal 2025. However, on a year-on-year basis, revenue declined 96% from $6.71 million in Q2 2024. Gross profit was $0.22 million, up 30% from $0.17 million in Q1 2025. The gross profit margin stood at 74.0%, compared to 83% in Q1 2025 and 5.0% in Q2 2024. Operational loss was $0.69 million, an improvement from $1.09 million in Q2 2024, representing a 36% reduction. Net loss narrowed to $0.23 million, compared to $0.95 million in Q1...

Aeries Technology, Inc. Reports Results for Third Fiscal Quarter 2025

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

North America Revenue Up 13.1% Year-Over-Year. Core adjusted EBITDA for the third fiscal quarter of 2025 was $1.50 million, compared to ($0.02) with the same period in 2024. NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a leading provider of global capability center (GCC) solutions, today announced financial results for the quarter ended December 31, 2024. “With the recent leadership changes, Aeries is strategically poised for the future, continuing our focus on serving high-quality, long-standing U.S. clients through Global Capability Centers.” said Ajay Khare, CEO of Aeries Technology. “We believe this clear direction, supported by a realigned cost structure and a robust team, firmly positions us for a return to profitable growth in both cash flow and Adjusted EBITDA....

DIH Announces Third Quarter 2025 Financial Results

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the third fiscal quarter ended December 31, 2024. Recent HighlightsRevenue of $15.1 million for the quarter ended December 31, 2024, representing a decline of 21% over the prior year period Device revenue of $11.7 million and service revenue of $3.1 million for the quarter ended December 31, 2024, representing a decline of 26% and growth of 4%, respectively, over the prior year...

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025

Written by Customer Service on February 14, 2025. Posted in Earnings Releases And Operating Results.

Received overwhelming shareholder support in favour of take-private transaction with Aditxt Advanced key pipeline programs, engaged regulatory authorities on ATI-1801 and preparing ATI-1701 for an Investigational New Drug submission Further strengthened government partnerships, reinforcing Appili’s position as a key player in biodefense and infectious disease solutions. HALIFAX, Nova Scotia, Feb. 14, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the third quarter of its fiscal year 2025, which ended on December 31, 2024. All figures are in Canadian dollars unless otherwise stated. “As we move into 2025, I...

Sound Financial Bancorp, Inc. Announces Annual Shareholders Meeting Date

Written by Customer Service on February 14, 2025. Posted in Public Companies.

SEATTLE, Feb. 14, 2025 (GLOBE NEWSWIRE) — Sound Financial Bancorp, Inc. (NASDAQ: SFBC) (the “Company”) announced today that the Company’s annual meeting of shareholders will be held on Tuesday, May 27, 2025. The record date for shareholders entitled to vote at the annual meeting will be March 31, 2025. About the Company Sound Financial Bancorp, Inc., a bank holding company, is the parent company of Sound Community Bank, and is headquartered in Seattle, Washington with full-service branches in Seattle, Tacoma, Mountlake Terrace, Sequim, Port Angeles, Port Ludlow and University Place. Sound Community Bank is a Fannie Mae Approved Lender and Seller/Servicer with one Loan Production Office located in the Madison Park neighborhood of Seattle, Washington. For more information, please visit www.soundcb.com. For additional information...

Day: February 14, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals